Explore All Access
Check if your research matches the topics covered in Chinese Journal of Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Chinese Journal of Oncology : Impact Factor & More
pISSN: 0253-3766
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Chinese Journal of Oncology Key Metrics
CiteScore 
1
Topics Covered on Chinese Journal of Oncology
Breast cancer
Pancreas
Progression-free survival
Overall survival
Lymph node
Cancer registry
Receiver operating characteristic
Western blot
Chemoradiotherapy
Computed tomography
Lymph node metastasis
Lung cancer
Total lesion glycolysis
Hepatocellular carcinoma
Esophageal squamous cell carcinoma
Multivariate analysis
Thyroid cancer
Flow cytometry
Human epidermal growth factor receptor
Cancer incidence
Chinese Journal of Oncology Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Chinese Medical Journals Publishing House Co.Ltd |
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Chinese Journal of Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chinese Journal of Oncology
[Advances in the treatment of anti-HER-2 antibody drug conjugates in pan-tumor with low HER-2 expression].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Cancer incidence and mortality in China, 2022].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Chinese expert consensus on iruplinalkib for the treatment of locally advanced or metastatic ALK-positive non-small cell lung cancer (2024 edition)].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Gemcitabine long-term maintenance chemotherapy benefits patients with survival: a multicenter, real-world study of advanced breast cancer treatment in China].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Advances in the treatment of anti-HER-2 antibody drug conjugates in pan-tumor with low HER-2 expression].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Cancer incidence and mortality in China, 2022].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Chinese expert consensus on iruplinalkib for the treatment of locally advanced or metastatic ALK-positive non-small cell lung cancer (2024 edition)].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Gemcitabine long-term maintenance chemotherapy benefits patients with survival: a multicenter, real-world study of advanced breast cancer treatment in China].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
[Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula].
- 23 Mar 2024
- Zhonghua zhong liu za zhi [Chinese journal of oncology]
Compare Similar Journals with Chinese Journal of Oncology
Select Journals to Compare with Chinese Journal of Oncology
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
BMC Cancer
Publisher: BMC
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
Medicine
Publisher: Elsevier
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Oncotarget
Publisher: Impact Journals
Cancers
Publisher: MDPI
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Scientific Reports
Publisher: NATURE PORTFOLIO
0 Journals Selected to compare with
Chinese Journal of Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Chinese Journal of Oncology
How many articles did Chinese Journal of Oncology publish last year? 
In 2023, Chinese Journal of Oncology publsihed 122 articles.
What is Citescore for Chinese Journal of Oncology?
Citescore for Chinese Journal of Oncology is 1.
Who is the publisher of Chinese Journal of Oncology?
Chinese Medical Journals Publishing House Co.Ltd is the publisher of Chinese Journal of Oncology.
